The Pfizer drug company is expected to seek authorization from the Food and Drug Administration for a coronavirus vaccine for children under 5 years old and as young as 6 months.
What could be the impact if a vaccine becomes available for children in this age group? To talk it all through is Dr. Meg Fisher, pediatric infectious disease specialist and special adviser to the commissioner of the state Department of Health.
